152609-41-1

Basic information

• Product Name: Heptanenitrile, 7-[[5-ethyl-2-(phenylmethoxy)[1,1'-biphenyl]-4-yl]oxy]-2,2-dimethyl-
• CAS NO: 152609-41-1
• Molecular Formula: C30H35NO2
• Molecular Weight: 441.613
• Mol File: 152609-41-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Heptanenitrile, 7-[[5-ethyl-2-(phenylmethoxy)[1,1'-biphenyl]-4-yl]oxy]-2,2-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Heptanenitrile, 7-[[5-ethyl-2-(phenylmethoxy)[1,1'-biphenyl]-4-yl]oxy]-2,2-dimethyl-(152609-41-1)
• EPA Substance Registry System: Heptanenitrile, 7-[[5-ethyl-2-(phenylmethoxy)[1,1'-biphenyl]-4-yl]oxy]-2,2-dimethyl-(152609-41-1)

Safety Data

• Hazardous Substances Data: 152609-41-1(Hazardous Substances Data)

Upstream product

• 4688-74-8 phenylboric acid 
• 152120-06-4 1-bromo-2-benzyloxy-4-(6-methyl-6-cyanoheptyloxy)-5-ethylbenzene 
• 98-80-6 phenylboronic acid 
• 29682-12-0 1-[4-(benzyloxy)-2-hydroxyphenyl]ethanone 
• 140660-32-8 2,2-dimethyl-7-chloroheptanenitrile 
• 152609-39-7 4-(benzyloxy)-2-<(6-methyl-6-cyanoheptyl)oxy>acetophenone 
• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 100-39-0 benzyl bromide 

Relevant articles and documents

Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease

This invention provides methods for the treatment or prevention of Alzheimer's disease which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene antagonist.

USE OF PLA2 INHIBITORS AS TREATMENT FOR ALZHEIMER'S DISEASE

This invention provides methods for the treatment or prevention of Alzheimer's disease in a mammal which comprises administering to a mammal in need thereof an effective amount of an inhibitor of phospholipase A2. This invention also provides a series of compounds which are useful as inhibitors of phospholipases A2, especially cytosolic phospholipase A2.

o-Phenylphenols: Potent and orally active leukotriene B4 receptor antagonists [3]

-